For more information, call us at 714-456-8000 or fill out an appointment request form . Our faculty members are subspecialty-trained, board-certified hematologists and oncologists who care for inpatients at UCI Medical Center and outpatients at Chao Family Comprehensive Cancer Center, which is the only National Cancer Institute-designated comprehensive cancer center in Orange County and one of only 50 in the nation. These include solid-tumor cancers such as melanoma, colorectal, breast and prostate cancer, as well asmalignancies of the blood, such as leukemia and lymphoma. Experience being involved in non-cancer therapeutics development in addition to the cancer experience is a plus When expanded it provides a list of search options that will switch the search inputs to match the current selection. Faculty members in these divisions provide clinical services at CHOC Childrens Hospital. Phone: (714) 456-7511 Fax: (714) 456-6025 Email: obrien@uci.edu University of California, Irvine 101 The City Drive South Building 23, Room 405 Mail Code: 2675 Orange, CA 92868 Research Interests Hematologic malignancies, both acute and chronic leukemia URL Chao Family Comprehensive Cancer Center Publications Dr. Sender, medical director of the oncology services team at the Chao Family Comprehensive Cancer Center, is a nationally known expert in disorders of the blood and lymphatic system. Use MyChart to schedule appointments, request prescription renewals, send messages to your care team and more. Professor of Medicine, Biological Chemistry and Public Health. We offer lifesaving treatment options for blood and lymph cancer patients with the launch of Orange County's first adult stem cell transplant and cellular therapy program. Welcome to the Division of Hematology/Oncology at UC Irvine's School of Medicine. Uci heme onc fellows. The University of California is a major NIH funded academic institute and offers a variety of research opportunities ranging from basic molecular biology to translational clinical trials and health outcomes are available. Diversity is core to our ability to offer compassionate and culturally competent care in a variety of practice settings, to patients from all walks of life, addressing simple to complex healthcare needs, while working with others who embrace a broad variety of backgrounds, experience, and perspectives. This, we believe, is vital to our ability to continue to achieve excellence in serving our richly diverse community through our discover, teach, and heal mission. Formal teaching and attending rounds are held daily at the medical center in Orange and at the VA in Long Beach. Home. These may include magnetic resonance imaging (MRI), computed tomography (CT) scans, positron emission tomography (PET) scans, endoscopy, X-rays and biopsies. . One of our goals is to help you confront any fears and develop a proactive attitude that encourages healing. Fellows receive a thorough grounding in general hematology, hematologic malignancy and solid tumors. The Hematology/Oncology PRN facilitates the timely dissemination of information related to the clinical practice, research, and teaching of hematology and oncology among its members and serves as a resource for hematology and oncology expertise to others. We are recognized for delivering the highest quality care by the Quality OncologyPractice Initiative (QOPI) CertificationProgram, which is an affiliate of the American Society of Clinical Oncology. Learn how Michelle Clark-Salib fought cancer and delivered a healthy son, Learn how Alwyn Kong's esophageal cancer was cured without an incision , Learn how a bone marrow transplant has given Sean Ramos his life back , Sign up for our monthly e-newsletter and get the latest health tips and stories from our Live Well blog . All rights reserved. We are the most comprehensive resource of this type in Orange County. Stem Cell Transplant rotations are held at the UCIMC. Contact. We are also a Blue Distinction Center for Complex and Rare Cancers. Irvine, CA . The division's faculty members serve patients with hematologic and oncologic disorders at the medicalcenter, which is consistently listedamong the top 50 U.S. hospitals by U.S. News & World Report, as well as at the VA Long Beach Healthcare System. The oncology division provides comprehensive care for children with childhood cancers such leukemia and solid tumors. He also has served as principal investigator on multiple clinical trials, including investigator-initiated trials. We remain committed to advancing diversity, in its broadest sense, in our programs through recruitment, training, retention and mentoring. Research To solve this problem, a privacy-preserving . In addition to conventional treatments, our medical oncologists are also active in clinical testing of novel therapies. bone marrow transplantation, chimeric antigen receptor (CAR) T-cell therapy, natural killer cell therapy. It also underscores our commitment to cancer prevention research as well as our extensive community outreach and education programs. Fellows' List of Research Publications 2010-2018 (fellows names appear in bold), Associate Program Director Lisa X. Lee, MD, Associate Program Diorectr Ann Eapen, MD, Research Rotation Director Angela Fleischman, MD, PhD, Division Chief: Edward L. Nelson, MD, FACP, Christopher SongEducation Programs Assistant AnalystPhone: 714-456-6589Fax: 714-456-2242E-mail: csong3@uci.edu, The Division of Hematology/OncologyUCI Medical Center101 The City Drive SouthBuilding 56, Room 239, ZOT 4061Orange, CA 92868, University of California, Irvine Irvine, CA 92697, Accreditation Council for Graduate Medical Education (ACGME), American Board of Internal Medicine (ABIM), Educational Commission for Foreign Medical Graduates (ECFMG), Electronic Residency Application Service (ERAS), A novel method for demonstrating cold agglutinin disease: a case report, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905110/, Secondary hemophagocytic lymphohistiocytosis in the setting of metastatic renal cell carcinoma: a case report, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333406/, PD-1 and PD-L1 as emerging therapeutic targets in gastric cancer: current evidence, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533281/, Prostatic Lymphoma Masquerading as Urinary Retention and Hematuria With Review of Literature, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650011/, http://pancreas.imedpub.com/pancreatic-neuroendocrine-tumors-therapy.pdf, Inotuzumab ozogamicin for the treatment of patients with acute lymphocytic leukemia, https://journals.prous.com/journals/servlet/xmlxsl/pk_journals.xml_summaryn_pr?p_JournalId=4&p_RefId=2737934, Treatment of pregnancy associated metastatic hormone and Her-2 receptor positive inflammatory breast cancer: A real challenge, https://doi.org/10.1016/j.ctarc.2016.09.003, https://www.sciencedirect.com/science/article/pii/S2468294216300739, Deadly Portland Cement: The Triad of Pulmonary, Dermatologic and Hematological Manifestations, https://www.sciencedirect.com/science/article/pii/S0002962916301379?via%3Dihub, BRAFV600E Mutations in High Grade Colorectal Neuroendocrine Tumors May Predict Responsiveness to BRAF-MEK Combination Therapy, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008024/, Primary Hepatic Osteosarcoma: A Rare Cause of Primary Liver Tumor, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827792/. Edward L. Nelson, MD, FACP Chief The emphasis is on understanding the pathologic process of diseases, the resulting functional changes, their clinical manifestations and complications, as well as diagnostic methodology, standard and experimental therapeutic modalities, clinical trials and research. Applicants also should be able to demonstrate their interest in the subspecialties of hematology and oncology. All rights reserved. We also offer theonly adult hematopoietic stem-cell transplant servicesin Orange County, allowing many patients to get this life-saving treatment near home. The diseases we treat include red cell, white cell, platelet, coagulation and immune system disorders, as well as cancers of every organ system. University of California, Irvine Irvine, CA 92697, National Cancer Institute-designated comprehensive cancer center. He sees patients at the UCI Health Chao Family Comprehensive Cancer Center in Orange. MD , Full Professor of Medical Oncology. Here at UCI Department of Medicine, we highly value diversity. Frank Meyskens, MD Director Emeritus, Chao Family Comprehensive Cancer Center. Through participation in clinical trials, patients at UCI Health can gain access to new therapies long before they become available to the general public. During the first year fellows acquire a panel of outpatients that are followed longitudinally throughout fellowship training in their continuity clinics. Our patients receive the best possible care because, as a comprehensive cancer center, we: Our multidisciplinary team of world-class oncologists, surgeons, radiation oncologists, pathologists, nurses, rehabilitation therapists, pharmacists, social workers and dietitians works together seamlessly to treat cancers of all types and degrees of severity. Medical Education. Treatments and therapies may include surgery, radiation and chemotherapy, individually or in combination, depending on your personal health and the type and stage of your cancer. Applications should be submitted as early as possible in order to meet ERAS deadlines for supporting documents and interview schedules. of complications from the coronavirus because of their compromised immune systems. Our modern infusion center allows our patients to undergo chemotherapy in privacy and comfort, attended by our team of experienced and compassionate nurses. Learn more about our research and clinical trials . If you are not already licensed in the state, contact the Medical Board of California at 1426 Howe Ave., Suite 54, Sacramento, CA 95825-3236. Application WindowOpen November 16, 2022 through Thursday, Nov 16, 2023 at 11:59pm (PacificSee this and similar jobs on LinkedIn. The multidisciplinary cancer center at UCI Medical Centeris supported by more than 200 UCI faculty members from five schools and 23 departments. As the only academic health system in Orange County, our multifaceted organization is dedicated to the discovery of new medical frontiers, to the teaching of . Michelle Clark-Salib fought cancer and delivered a healthy son, COVID-19 vaccine and protecting your health , National Cancer Institute-designated comprehensive cancer center in Orange County, only adult hematopoietic stem-cell transplant services, Our cancer experts also are available to provide second opinions , Hematology-Oncology Services (Leukemia, Lymphoma and Myeloma), Quality OncologyPractice Initiative (QOPI) CertificationProgram, Blue Distinction Center for Complex and Rare Cancers, Learn more about our Blue Distinction Center designation , 53 National Cancer Institute (NCI)-designated comprehensive cancer centers, HIPEC, or hyperthermic intraoperative peritoneal chemotherapy, Stem cell transplant wards off aggressive lymphoma, Dedicated to cancer research & treatment (video), OCMA honors UCI Health 'Physicians of Excellence', 2022 UCI Anti-Cancer Challenge raises record $1 million for promising cancer research, UCI Health honored for surgical safety and excellence, UCI opens first natural killer cell clinical trial for recurrent glioblastoma, $8 million grant expands access to UCI stem cell clinical trials, Gastric cancer patient gets new lease on life, Riding tall a decade after prostate surgery, A novel approach to advanced stomach cancer, Take a virtual tour of the infusion center at UCI Health Cancer Center Newport , Integrate innovative research with the most advanced diagnostics, treatments, rehabilitation and, Offer one of the largest early-phase clinical trials programs in Southern California, giving our patients access to promising therapies before they are available elsewhere. At the UCI Chao Family Comprehensive Cancer Center, we work to prevent, manage, and cure cancer so all people live healthier, longer lives. All rights reserved. Ciurea is the author of more than 150 peer-reviewed publications and more than 10 book chapters. The hematology division provides diagnostic, therapeutic and consultative care to children with hematologic disorders such as hemophilia, anemia and platelet disorders. Incumbent will be responsible for the development and growth of UCI's early phase clinical trials portfolio for both oncology and non-oncology indications, across the UCI Chao Family Comprehensive Cancer Center's (CFCCC) Stern Center for Cancer Clinical Trials & Research (Stern Center), the UCI Center for Clinical Research (CCR), and the UCI Alpha Stem Cell Clinic (ASCC).